Scientific work

Doç. Dr. Aysun Şentürk Yıkılmaz

94 publications. The source of the information is stated next to each publication.

Back to profile
  1. EFFECT OF THE INITIAL TREATMENT ON THE MUSCLE MASS AND RESPONSE TO THERAPY IN HODGKIN’S LYMPHOMA

    AYBU AVESIS, 2018

    Source: OpenAlex

  2. The Place of Interventional Hematologic Investigations in Unknown Fever Etiology

    Ankara Medical Journal, 2017

    DOI 10.17098/amj.370672 Open-access full textSource: OpenAlex

  3. Stimulated thyroglobulin values above 5.6 ng/ml before radioactive iodine ablation treatment following levothyroxine withdrawal is associated with a 2.38-fold risk of relapse in Tg-ab negative subjects with differentiated thyroid cancer.

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2017

    DOI 10.1007/s12094-017-1640-3 PMID 28258491 5 citations (Europe PMC) Source: ORCID

  4. DOES EARLY RESPONSE TO FIRST LINE CORTICOSTEROID THERAPY PREDICT REQUIREMENT FOR SECOND LINE THERAPY IN IMMUNE THROMBOCYTOPENIA

    Haematologica, 2017

    Source: ORCID

  5. TERAPÖTİK PLAZMAFEREZ, TROMBOTİK TROMBOSİTOPENİK PURPURA TEDAVİSİNDE ETKİLİ MİDİR?

    AYBU AVESIS, 2017

    Source: OpenAlex

  6. DOES FERRITIN AND VITAMIN B12 LEVELS HAVE PROGNOSTIC HAVE PROGNOSTIC SIGNIFICANCE IN MULTIPLE MYELOMA PATIENTS?

    AYBU AVESIS, 2017

    Source: OpenAlex

  7. HEMATOLOJİ KONSÜLTASYONLARI: TEK MERKEZ

    AYBU AVESIS, 2017

    Source: OpenAlex

  8. POLİSİTEMİ VERA OLGULARININ KARAKTERİSTİKLERİ, TEK MERKEZ DENENYİMİ

    AYBU AVESIS, 2017

    Source: OpenAlex

  9. ESANSİYEL TROMBOSİTOZ OLGULARININ TEK MERKEZDEN DEMOGRAFİK VERİLERİ

    AYBU AVESIS, 2017

    Source: OpenAlex

  10. DOES FERRITIN AND VITAMIN B12 LEVELS HAVE PROGNOSTIC SIGNIFICANCE IN MULTIPLE MYELOMA PATIENTS?

    AYBU AVESIS, 2017

    Source: OpenAlex

  11. ÇOK NADİR BİR DURUM OLARAK SOĞUK AGLÜTİNİN HASTALIĞI İLE GELEN SİSTEMİK LUPUS ERİTEMATOZİS OLGUSU

    AYBU AVESIS, 2017

    Source: OpenAlex

  12. MULTIPLE MYELOMA IN PATIENTS OLDER THAN 65 YEARS: A COMPARATIVE STUDY WITH YOUNGER ADULT MULTILE MYELOMA PATIENTS

    AYBU AVESIS, 2017

    Source: OpenAlex

  13. POLİSTEMİA VERA OLGULARININ KARAKTERİSTİKLERİ, TEK MERKEZ DENEYİMİ

    AYBU AVESIS, 2017

    Source: OpenAlex

  14. Multiple myeloma in patients older than 65 years: A comparative study with younger adult multiple myeloma patients

    AYBU AVESIS, 2017

    Source: OpenAlex

  15. TROMBOTİK TROMBOSİTOPENİK PURPURA OLGULARIMIZIN TERAPÖTİK PLAZMAFEREZ SONUÇLARI

    AYBU AVESIS, 2017

    Source: OpenAlex

  16. ERKEN EVRE KLL HASTALARININ 25 HİDROKSİ D VİTAMİNİ DÜZEYLERİ SAĞLIKLI POPULASYONDAN DÜŞÜKTÜR

    AYBU AVESIS, 2017

    Source: OpenAlex

  17. REANİMASYON YOĞUN BAKIM OLGULARINDA TERAPÖTİK PLAZMAFERZ: TEK MERKEZ DENEYİMİ

    AYBU AVESIS, 2017

    Source: OpenAlex

  18. ÇOK NADİR BİR DURUM OLARAK SOĞUK AGLÜTİNİN HASTALIĞI İLE GELEN SİSEMİK LUPU ERİTEMATOSİS OLGUSU

    AYBU AVESIS, 2017

    Source: OpenAlex

  19. Epidemiology of Vitamin B12 Deficiency

    InTech eBooks, 2016

    DOI 10.5772/63760 8 citations (OpenAlex) Open-access full textSource: OpenAlex

  20. TWO CASES OF ACQUIRED HEMOPHILIA A

    Thrombosis Research, 2016

    Source: ORCID

  21. MANAGEMENT OF PATIENTS WITH ACUTE LEUKEMIA WHO HAD ALLOIMMUNE THROMBOCYTOPENIA UNTIL RECOVERY PERIOD

    AYBU AVESIS, 2016

    Source: OpenAlex

  22. THE CRYOPRECIPITATE REPLACEMENT FOR THE ACUTE PROMYELOCYTIC LEUKEMIA CASES WHOPRESENTED WITH HYPOFIBRINOGENEMIA

    AYBU AVESIS, 2016

    Source: OpenAlex

  23. The distrubution of component use according to clinics single center experience

    AYBU AVESIS, 2016

    Source: OpenAlex

  24. Hodgkin lenfomada PD-1, PD-L1 eksresyonunun EBV (Ebstein Barr Virus) ile ilişkisi ve prognostik önemi

    AYBU AVESIS, 2016

    Source: OpenAlex

  25. THE DISTRUBUTION OF COMPONENT USE ACCORDİNG TO CLINICS SINGLE CENTER EXPERIENCE

    AYBU AVESIS, 2016

    Source: OpenAlex

  26. THREE YEAR EXPERIENCE TRANSITION FROM REGIONAL BLOOD CENTER TO TRANSFUSION CENTER

    AYBU AVESIS, 2016

    Source: OpenAlex

  27. THE CRYOPRECIPITATE REPLACEMENT FOR THE ACUTE PROMYELOCYTIC LEUKEMIA CASES WHO PRESENTED WITH HYPOFIBRINOJENEMIA

    AYBU AVESIS, 2016

    Source: OpenAlex

  28. THE DISTRUBUTION OF COMPONET USE ACCORDING TO CLINICS SINGLE CENTER EXPERIENCE

    AYBU AVESIS, 2016

    Source: OpenAlex

  29. HODGKİN LENFOMADA PD-1, PD-L1EKSPRESYONUNUN EBV(EPSTEİN-BARR VİRUS)İLE İLİŞKİSİ VE PROGNOSTİK ÖNEMİ

    AYBU AVESIS, 2016

    Source: OpenAlex

  30. LEAST INCOMPATIBLE RED BLOOD CELL UNIT USING HOW SAFETY DECISION

    AYBU AVESIS, 2016

    Source: OpenAlex

  31. The predictive value of epidemiological characteristics, clinical and laboratory findings in adult lymphadenopathy etiology.

    PubMed, 2015

    PMID 26367715 6 citations (OpenAlex) Source: OpenAlex

  32. EDTA-Dependent Pseudothrombocytopenıa in an Elderly Patient with Rheumatoid Arthritis: A Case Report

    Gazi Medical Journal, 2015

    DOI 10.12996/gmj.2015.62 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  33. The predictive value of epidemiological characteristics, clinical and laboratory findings in adult lymphadenopathy etiology

    European Review for Medical and Pharmacological Sciences, 2015

    Source: ORCID

  34. Cerebral venous sinus thrombosis in acute promyelocyticleukemia APL a possible association to ATRA

    AYBU AVESIS, 2015

    Source: OpenAlex

  35. INTENSE MANAGEMENT OF ELDERLY ACUTE MYELOID LEUKEMIA YES

    AYBU AVESIS, 2015

    Source: OpenAlex

  36. Diffuse large B cell lymphoma and plasma cell myeloma developing years after theraphy for hodgkin lymphoma

    AYBU AVESIS, 2015

    Source: OpenAlex

  37. Bluriness differential diagnosis don t forget acute promyelocytic leukemia

    AYBU AVESIS, 2015

    Source: OpenAlex

  38. Peripheral T cell lymphomas analysis of 11 cases from a single center

    AYBU AVESIS, 2015

    Source: OpenAlex

  39. WHAT SHOUL BE THE RIGHT TIME FOR THE CHELATION THERAPY IN MYELODYSPLASTIC SYNDROME

    AYBU AVESIS, 2015

    Source: OpenAlex

  40. WE WOULD NOT OVERLOOK ENDOCRINE DISORDERS IN ANEMIA

    AYBU AVESIS, 2015

    Source: OpenAlex

  41. AN IMPORTANT PROGNOSTIC FACTOR IN ACUTE LEUKEMIA INFECTION

    AYBU AVESIS, 2015

    Source: OpenAlex

  42. Unexpected adverse effect of cloforabin bronze hyperpigmentation

    AYBU AVESIS, 2015

    Source: OpenAlex

  43. BLURRINESS DIFFERANTIAL DIAGNOSIS DON T FORGET ACUTE PROMYELOCYTIC LEUKEMIA

    AYBU AVESIS, 2015

    Source: OpenAlex

  44. Stimulated serum Tg ≥0.285 ng/ml in anti-Tg(−) cases had 3.087 times increased likelihood of recurrence of differentiated thyroid cancer: a single center experience

    Endocrine Abstracts, 2013

    DOI 10.1530/endoabs.32.p1104 Source: OpenAlex